Looking for the best password manager for your business? Here are the top options, no matter your budget.
Pfizer: One of the world’s premier biopharmaceuticBNamericas provides takeaways from comments submitted by stakeholders to proposed modifications to the transmission regulation, which establishes the rates p...
Pfizer: One of the world’s premier biopharmaceuticTarcocimab noninferior to aflibercept while cutting treatment burden in half
Pfizer: One of the world’s premier biopharmaceuticDeucravacitinib bestows benefits in Asian patients with plaque psoriasis
Pfizer: One of the world’s premier biopharmaceuticRedTech • Technology publication and platform created by multicultural professionals especially for the international radio broadcast and digital audio industries.
Pfizer: One of the world’s premier biopharmaceuticClassic psychedelic research is rapidly expanding...
Zanubrutinib elicited significantly higher response rates and survival benefits compared with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma .
TALZENNA® first PARP inhibitor to demonstrate clinical benefit in combination with XTANDI ® in metastatic castration-resistant prostate cancer (mCRPC) Study achieves primary endpoint of radiographic progression-free survival Robust, highly consistent efficacy demonstrated in mCRPC both with or witho…
Pfizer: One of the world’s premier biopharmaceuticNew drive provides military-grade encryption in a waterproof, fireproof package ensuring data safety. VANCOUVER, Wash.--(BUSINESS WIRE)-- Already the recognized leader in onsite data protection, ioSafe® today introduced...
Good response rate with camidanlumab tesirine, although a lot of patients experienced AEs
MedpageTodayBrensocatib has no impact on COVID-19 clinical outcomes
MedpageTodayBAGUIO CITY: Unlike the boarding houses and accommodation establishments (AEs) in three villages earlier inspected by the Summer Capital’s composite team, those at Barangay...
MedpageTodayDosing 8 mg every 12 or 16 weeks for DME, AMD matches results with 2 mg every 8 weeks
MedpageTodayDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we’ll want...
Shares of AES Corp. slumped 0.66% to $22.60 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...
SURPERFORMANCEPlans call for the development of an economic development hub
SURPERFORMANCEDPA Microphones will showcase its esteemed studio and live sound microphone solutions at the 2022 AES New York Show (Booth 328). Designed to deliver DPA’s renowned crystal-clear, natural audio, these mics are ideal for any audio professional working in the live production sphere, as well as in the s
SURPERFORMANCEResults from the POLARIX clinical trial support the use of polatuzumab vedotin plus rituximab as frontline treatment for diffuse large B-cell lymphoma.
In the absence of a head-to-head trial, the researchers compiled data from randomized controlled trials of the 2 PD-1/PD-L1 inhibitors in patients with advanced disease and PD-L1 ≥ 50%.
What’s next for Egwene?
SURPERFORMANCE
